Biovica International AB (9II.MU)

0.0690

0.0000

(0.00%)

At close: April 30 at 8:04:26 AM GMT+2

DiviTum(R) TKa Data in Combination with Inflammation Proteins Presented at the AACR Meeting Enhance Precision to Predict Efficacy of Immunotherapy

UPPSALA, SE / ACCESS Newswire / March 26, 2025 /Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, a leader in blood-based biomarker assays in oncology, today announces that an abstract with DiviTum TKa in a biomarker algorithm will ...

ACCESS Newswire last month

9II.F
Biovica Q3 Interim report Nov 2024 - Jan 2025

UPPSALA, SE / ACCESS Newswire / March 13, 2025 /Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Quarterly sales doubled, expanding market potential exponentially SEK t Q3 24/25 Q3 23/24 May-Jan 24/25 May-Jan 23/24 Full year 23/24 Net sales ...

ACCESS Newswire last month

9II.F
Biovica and Outcomes4Me Partner to Support Metastatic Breast Cancer Patients to Better Understand the Effectiveness of their Treatment

UPPSALA, SE / ACCESS Newswire / March 12, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Today, Biovica, a leader in blood-based cancer monitoring, announces a partnership with Outcomes4Me, the developer of the leading direct-to-patient ...

ACCESS Newswire last month

9II.F
Biovica Signs New Work Order with US Biotech Company for TKa Testing Services

UPPSALA, SE / ACCESS Newswire / March 10, 2025 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, has secured a new work order (WO) valued at SEK 2.5 million for TKa testing services within ...

ACCESS Newswire last month

9II.F
Biovica Signs Agreement With Eurobio Scientific Covering 60 Percent of European Market

UPPSALA, SE / ACCESS Newswire / March 5, 2025 /Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, has signed a collaboration agreement with Eurobio Scientific, a leading French group in in vitro specialty ...

ACCESS Newswire last month

9II.F
Board Member of Biovica Resigns at Own Request

Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica today announces that board member Ulf Jungnelius has resigned from the board at his own request, with immediate effect. Personal reasons are behind the decision. "Due to my current ...

ACCESS Newswire 2 months ago

9II.F
Nomination Committee for Biovica International AB for the 2025 Annual General Meeting

Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) The Nomination Committee prior to the 2025 Annual General Meeting will consist of three members, who shall represent the two shareholders with the highest number of shares who accept the ...

ACCESS Newswire 2 months ago

9II.F
Biovica Secures Major Work Order for TKa Testing Services

UPPSALA, SE / ACCESSWIRE / January 13, 2025 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, has signed an order with a total value of 2.3 MSEK for TKa testing services within its Pharma ...

ACCESS Newswire 3 months ago

9II.F
Agreement Signed with US Insurance Giant and Expanded Market

UPPSALA, SE / ACCESSWIRE / December 12, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) SEK t Q2 24/25 Q2 23/24 May-Oct 24/25 May-Oct 23/24 Full year 23/24 Net sales 2,312 2,563 4,027 4,316 7,290 Operating profit (loss) -19,753 ...

ACCESS Newswire 4 months ago

9II.F
Biovica CLIA Lab Achieves New York State Permit that Opens the Entire US Market

UPPSALA, SE / ACCESSWIRE / December 06, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, today announces that the company has obtained an out-of-state permit allowing Biovica to ...

ACCESS Newswire 4 months ago

9II.F
Biovica Signs Agreement with American Health Giant

UPPSALA, SE / ACCESSWIRE / December 02, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, today announces that the company has entered into a commercial agreement (client bill) with ...

ACCESS Newswire 4 months ago

9II.F
New DiviTum(R) TKa data to be Presented at SABCS that Significantly Broaden the Addressable Market

UPPSALA, SE / ACCESSWIRE / November 26, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Biovica, active in cancer monitoring, announces that seven abstracts based on studies using the blood test DiviTum TKa will be presented at ...

ACCESS Newswire 5 months ago

9II.F
Biovica signs agreement with UK biotech company

UPPSALA, SE / ACCESSWIRE / October 22, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, has signed a Master Service Agreement (MSA) for TKa testing with a UK-based pharma biotech ...

ACCESS Newswire 6 months ago

9II.F
Biovica Announces Outcome of Exercise of Warrants of Series To 3 B

UPPSALA, SWEDEN / ACCESSWIRE / October 3, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica International AB ("Biovica" or the "Company") announces today the outcome of the exercise of warrants of series TO 3 B issued in connection ...

ACCESS Newswire 6 months ago

9II.F
Biovica Announces Subscription Commitments in Ongoing TO3B Program

UPPSALA, SWEDEN / ACCESSWIRE / September 24, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Monday, September 30, 2024, is the last day for subscription in Biovica's ongoing warrant program, TO3B. Note that some banks and asset ...

ACCESS Newswire 7 months ago

9II.F
Biovica Signs Significant Work Order for TKa Testing Services

UPPSALA, SE / ACCESSWIRE / September 23, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, has signed a work order with a value of 2.2 MSEK. This is the company's largest single work ...

ACCESS Newswire 7 months ago

9II.F
Announcement from Biovica International AB's Annual General Meeting

UPPSALA, SE / ACCESSWIRE / September 17, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) The annual general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 17 September 2024 and the following resolutions ...

ACCESS Newswire 7 months ago

9II.F
Biovica Signs Agreement with Clinical-Stage US Biotech Company

UPPSALA, SE / ACCESSWIRE / September 17, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, has signed a Master Service Agreement (MSA) with a US-based biotech company focusing on next ...

ACCESS Newswire 7 months ago

9II.F
Correction: Q1 Interim Report May-July 2024/2025

Correction due to missing MAR-legend UPPSALA, SE / ACCESSWIRE / September 12, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Significantly increased sales in the USA and much improved cash flow SEK t Q1 24/25 Q1 23/24 May-April ...

ACCESS Newswire 7 months ago

9II.F
Q1 Interim Report May-July 2024/2025

UPPSALA, SE / ACCESSWIRE / September 12, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Significantly increased sales in the USA and much improved cash flow SEK t Q1 24/25 Q1 23/24 May-April 23/24 Net sales 1,714 1,766 7,290 Operating ...

ACCESS Newswire 7 months ago

9II.F

Performance Overview

Return	9II.MU	OMX Stockholm 30 Index (^OMX)
YTD	-56.71%	-1.98%
1-Year	-58.48%	-4.79%
3-Year	-97.50%	+18.22%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

Biovica International AB (9II.MU)

DiviTum(R) TKa Data in Combination with Inflammation Proteins Presented at the AACR Meeting Enhance Precision to Predict Efficacy of Immunotherapy

Biovica Q3 Interim report Nov 2024 - Jan 2025

Biovica and Outcomes4Me Partner to Support Metastatic Breast Cancer Patients to Better Understand the Effectiveness of their Treatment

Biovica Signs New Work Order with US Biotech Company for TKa Testing Services

Biovica Signs Agreement With Eurobio Scientific Covering 60 Percent of European Market

Board Member of Biovica Resigns at Own Request

Nomination Committee for Biovica International AB for the 2025 Annual General Meeting

Biovica Secures Major Work Order for TKa Testing Services

Agreement Signed with US Insurance Giant and Expanded Market

Biovica CLIA Lab Achieves New York State Permit that Opens the Entire US Market

Biovica Signs Agreement with American Health Giant

New DiviTum(R) TKa data to be Presented at SABCS that Significantly Broaden the Addressable Market

Biovica signs agreement with UK biotech company

Biovica Announces Outcome of Exercise of Warrants of Series To 3 B

Biovica Announces Subscription Commitments in Ongoing TO3B Program

Biovica Signs Significant Work Order for TKa Testing Services

Announcement from Biovica International AB's Annual General Meeting

Biovica Signs Agreement with Clinical-Stage US Biotech Company

Correction: Q1 Interim Report May-July 2024/2025

Q1 Interim Report May-July 2024/2025

Performance Overview